On February 1, 2023, Cosmos Health Inc. (the 'Company') announced the appointment of Nikos Bardakis (54), who comes with over two decades of international branded pharmaceutical sector experience, as the Chief Operating Officer (COO).
Nikos Bardakis will succeed Pavlos Ignatiades, who will assume the position of Chief Communications Officer (CCO).
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Nikos Bardakis was appointed as Chief Operating Officer (COO) at Cosmos Health Inc..
Action
appointed
Role
Chief Operating Officer (COO)
Exact text from the filing
On February 1, 2023, Cosmos Health Inc. (the 'Company') announced the appointment of Nikos Bardakis (54), who comes with over two decades of international branded pharmaceutical sector experience, as the Chief Operating Officer (COO).
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.